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Abstract
Highly pathogenic avian influenza viruses of the H5N1 subtype continue to threaten agriculture and human health. Here,
we use biochemistry and x-ray crystallography to reveal how amino-acid variations in the hemagglutinin (HA) protein
contribute to the pathogenicity of H5N1 influenza virus in chickens. HA proteins from highly pathogenic (HP) A/chicken/
Hong Kong/YU562/2001 and moderately pathogenic (MP) A/goose/Hong Kong/437-10/1999 isolates of H5N1 were found to
be expressed and cleaved in similar amounts, and both proteins had similar receptor-binding properties. However, amino-
acid variations at positions 104 and 115 in the vestigial esterase sub-domain of the HA1 receptor-binding domain (RBD)
were found to modulate the pH of HA activation such that the HP and MP HA proteins are activated for membrane fusion at
pH 5.7 and 5.3, respectively. In general, an increase in H5N1 pathogenicity in chickens was found to correlate with an
increase in the pH of HA activation for mutant and chimeric HA proteins in the observed range of pH 5.2 to 6.0. We
determined a crystal structure of the MP HA protein at 2.50 A ˚ resolution and two structures of HP HA at 2.95 and 3.10 A ˚
resolution. Residues 104 and 115 that modulate the acid stability of the HA protein are situated at the N- and C-termini of
the 110-helix in the vestigial esterase sub-domain, which interacts with the B loop of the HA2 stalk domain. Interactions
between the 110-helix and the stalk domain appear to be important in regulating HA protein acid stability, which in turn
modulates influenza virus replication and pathogenesis. Overall, an optimal activation pH of the HA protein is found to be
necessary for high pathogenicity by H5N1 influenza virus in avian species.
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Introduction
Highly pathogenic avian influenza (HPAI) viruses kill up to
100% of infected poultry flocks and may cause high mortality rates
when transmitted to humans [1,2]. For example, H5N1 influenza
viruses have contributed to the deaths of 331 of 565 individuals
since 2003 [3] and are endemic in domestic poultry in Egypt and
Indonesia [4]. The continued circulation of H5N1 and potential
emergence of an H5N1 human pandemic virus remain ever-
present threats.
The hemagglutinin (HA) surface glycoprotein promotes viral
entry through its receptor binding and membrane fusion functions
[5], and mutations in HA have been shown to modulate the
pathogenicity, host range specificity, transmissibility, and pan-
demic potential of influenza viruses [1,6,7]. HA is synthesized as a
trimeric HA0 protein that must be activated for membrane fusion
by post-translational cleavage into a high-energy HA1/HA2
complex. The multi-basic HA0 cleavage sites of H5 and H7
HPAI viruses are recognized by ubiquitously expressed intracel-
lular proteases, facilitating systemic virus spread and greater
pathogenicity [8–10]. HA binds to sialic acid-containing receptors
on the surfaces of host cells [5], and the specificity of receptor
binding helps determine host range, with avian and human viruses
preferentially binding to a(2,3) and a(2,6) sialosides, respectively
[11,12]. Upon internalization, the virus is exposed to progressively
lower pH values until a threshold is reached that triggers HA to
undergo irreversible conformational changes that mediate mem-
brane fusion [13]. Mutations that modulate HA acid stability have
been associated with the adaptation of influenza viruses to
different host species and cell lines [14,15], and HA acid stability
has recently been identified as a potential virulence factor [16].
Some influenza viruses contain all of the known genetic
elements for high pathogenicity yet are attenuated in vivo. For
example, the clade 3 H5N1 isolate A/goose/Hong Kong/437-10/
1999 has significantly lower replication and pathogenicity in
chickens compared to the closely related isolate A/chicken/Hong
PLoS Pathogens | www.plospathogens.org 1 December 2011 | Volume 7 | Issue 12 | e1002398Kong/YU562/2001 [17]. The attenuating amino-acid residues
have been mapped to the receptor-binding sub-domain and the
vestigial esterase sub-domain in the HA1 receptor-binding domain
(RBD) in the HA protein. However, the HA proteins from both
isolates contain markers typical of high pathogenicity including a
polybasic cleavage site, identical glycosylation sites, and identical
residues in the receptor-binding pocket. The goal of the current
study was to determine the molecular mechanism by which the
naturally occurring variations in the HA protein modulate H5N1
pathogenicity.
Results
MP and HP HA proteins have different acid stabilities
To determine how the HA proteins from the two isolates differ
in their biochemical properties, the proteins were expressed in cell
culture and compared for expression, cleavage, receptor binding,
and activation pH (Figure 1, S1). The neuraminidase (NA)
proteins were co-expressed with the HA proteins because of the
known interplay between HA and NA with respect to receptor
binding [18] and membrane fusion [16,19,20]. Western blot and
flow cytometric analyses revealed no significant differences in total
or cell-surface expression of the two HAs when co-expressed with
NA from either isolate (Figure 1A,B and Figure S1). The ratios of
cleaved (HA1+HA2) to uncleaved (HA0) species were also similar
for the two HAs (Figure 1A). To investigate potential differences in
avian receptor-binding avidity, we quantified the amount of
chicken and turkey erythrocytes adsorbed to HA-expressing cells
and found no difference (Figure 1C). Overall, these data show that
the amino-acid variations in the HA and NA proteins from the MP
and HP isolates do not result in substantial differences in HA
protein expression, cleavage, or receptor binding.
We next compared the activation pH values of the two HA
proteins. Flow cytometry was used to measure pH-induced
conformational changes by using monoclonal antibodies VN04-
09 and VN04-16 that preferentially bind to the prefusion and
postfusion forms of the H5N1 HA protein, respectively [19,21].
When co-expressed with the homotypic NA partner, conforma-
tional changes by MP HA were first observed at pH 5.4, reached a
midpoint at pH 5.3, and were complete at pH 5.1–5.2 depending
on the antibody (Figure 1E). In contrast, conformational changes
by HP HA were triggered at higher pH (,0.4 pH units) being first
observed at pH 5.8, reaching a midpoint at pH 5.7, and being
complete at approximately pH 5.4 (Figure 1D). Comparing the
midpoints of conformational changes, MP HA had a value of
pH 5.3 whereas HP HA had a value of 5.7, showing that HP HA
is less acid stabile than MP HA. To determine the highest pH at
which the HA proteins promote membrane fusion, syncytia assays
were performed in BHK-21 cells. Consistent with the flow
cytometry results, MP HA triggered membrane fusion at pH 5.3
when co-expressed with its MP NA partner, and HP HA triggered
fusion at pH 5.7 when co-expressed with its HP NA partner
(Figure 1F). The syncytia assays were repeated using BHK-21 cells
infected with the MP 437-10 and HP YU562 viruses. In virus-
infected cells, MP HA was activated to cause membrane fusion at
pH 5.2, and HP HA promoted membrane fusion at pH 5.6.
Therefore, during either infection or transient expression, HP HA
was destabilized by 0.4 pH units compared to MP HA.
We have recently shown that NA enzymatic activity increases
the activation pH of the H5N1 HA protein [16]. Therefore, we
next investigated whether potential differences in the activities of
NA proteins from the HP YU562 and MP 437-10 viruses might
affect HA acid stability. We first measured the activities of HP and
MP NA when transiently co-expressed with their homotypic HA
protein and found that HP NA had significantly more activity than
MP NA (P,0.05; unpaired two-tailed t test) (Figure 2A). Second,
we measured the NA activities of HP and MP viruses in vitro and
found once again that the HP virus had significantly more NA
activity than the MP virus (P,0.01; unpaired two-tailed t test)
(Figure 2B). Third, we measured the pH of activation of the HAs
when co-expressed with either the HP or MP NA protein
(Figure 1F). MP HA was activated at a higher pH of 5.45 when
co-expressed with the more active, heterotypic HP NA compared
to co-expression with the less active, homotypic MP NA (pH of
5.3). HP HA was activated at a lower pH of 5.4 when co-expressed
with the less active, heterotypic MP NA compared to co-
expression with the more active, homotypic HP NA (pH of 5.7).
In summary, we found that the HA protein from the HP YU562
virus was activated at a higher pH than the HA protein from the
MP 437-10 virus, and increased NA activity from the HP YU562
virus was associated with a further increase in the pH of HA
activation.
Residues that regulate HA acid stability
The HA proteins of MP 437-10 and HP YU562 viruses differ by
7 amino-acid residues in HA1. Residues 104 and 115 are at the
ends of the 110-helix in the vestigial esterase sub-domain of the
RBD, 131 and 142 are distal to the receptor-binding pocket in the
receptor-binding sub-domain, 216 and 221 are at the interface of
receptor-binding sub-domain protomers, and 331 is within the
polybasic cleavage site [17]. To identify the residues that are
responsible for altering HA acid stability, we introduced mutations
into the HP HA that correspond to those found in the MP HA,
either individually or in combination. We introduced the
mutations into the HP HA, rather than vice versa, because
chicken LD50 values for influenza viruses containing analogous
mutations were previously made in the background of the 8 gene
segments of the HP virus [17]. We then measured the biochemical
properties of the mutant HP HA proteins when co-expressed with
the homotypic HP NA protein. We initially focused on three
chimeric HP HA proteins: rHA1 (D104N/I115T/E131D/
Author Summary
To deliver their genomes into host cells during entry,
enveloped viruses contain glycoproteins that bind to
cellular receptors and cause fusion of viral and cellular
membranes. The influenza virus HA protein is the
archetypal viral fusion glycoprotein, promoting entry by
undergoing irreversible structural changes that drive
membrane merger. HA trimers on the surfaces of
infectious influenza virions are trapped in a metastable,
high-energy conformation and are triggered to refold and
cause membrane fusion after the virus is internalized and
exposed to low pH. Here, we provide biochemical and x-
ray crystallographic evidence that naturally occurring
amino-acid variations at the interface of the vestigial
esterase and fusogenic stalk domains alter HA acid stability
for highly pathogenic H5N1 influenza, resulting in a shift in
the threshold pH required to activate HA protein structural
changes that cause membrane fusion. Furthermore, our
data reveals that an increased HA activation pH correlates
with increased H5N1 virulence in chickens. Overall, the
acid stability of the HA protein is identified as a novel
virulence factor for emerging H5N1 influenza viruses. A
major implication of this work is that the fitness of
enveloped viruses may be fine-tuned by mutations that
alter the activation energy thresholds of their fusion
glycoproteins.
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three chimeric proteins displayed altered levels of expression,
cleavage, or receptor-binding avidity of the HP HA protein
(Figure 3). The E331K mutation in the polybasic cleavage site of
rHA5 did not affect the HA activation pH (Figure 3A). The
mutant HP HA protein containing K216E/S221P mutations
(rHA3) was also not responsible for decreasing the pH of
activation, but instead had the opposite effect by raising the pH
of activation of the HP HA protein to 6.0 (Figure 3A) due to the
presence of the K216E mutation (Figure S2).
The rHA1 chimeric HP HA protein containing 4 mutations
(D104N/I115T/E131D/L142H) was previously shown to reduce
the pathogenicity of HP YU562 virus in chickens [17], and in this
study we found that the rHA1 mutations reduced the activation
pH of HP HA from 5.7 to 5.35 (Figure 3A), a value similar to that
of MP HA. To identify the responsible residue(s), we generated HP
HA proteins that contained either single (D104N, I115T, E131D,
or L142H) or double (D104N/I115T or E131D/L142H)
mutations. A reduced activation pH was only present in the
D104N/I115T double mutant, which was triggered at pH 5.45, a
value identical to that of the MP HA protein when co-expressed
with the HP NA protein (Figure 3). Therefore, our data suggest
that changes at residues 104 and 115 contribute to the difference
in the activation pH values of the HP and MP HA proteins.
Relationship between HA acid stability and H5N1
pathogenicity
We next compared our measurements of HA activation pH to
the values of 50% lethal dose (LD50) in chickens that had been
infected with H5N1 viruses containing equivalent HA mutations
[17]. An increase in the pH of activation of the HA protein
correlated (R
2=0.82) with an increase in pathogenicity, repre-
sented as the reciprocal of LD50 (Figure 4). HP HA and rHA3
Figure 1. Characterization of the HP and MP HA proteins. (A) Western blot of HA expression. Values below the HA2 bands are the cleavage
ratio, calculated by dividing HA2 by total HA (i.e., HA0 + HA2). The values listed are the mean of 3 independent experiments. (B) HA protein
expression. Total expression (solid bars) was measured by Western blot and surface expression (open bars) was measured by flow cytometry. Values
were normalized to 100 % for HP HA (+ HP NA). (C) Hemadsorption of chicken and turkey erythrocytes to cell surface-expressed HA proteins. Bound
erythrocytes were lysed, and released hemoglobin was measured at 415 nm. Values were normalized to 100% for HP HA (+ HP NA). (D and E)p Ho f
HA protein conformational changes. HP and MP HA proteins were co-expressed with their homologous NA proteins. Activation pH values for HA
proteins were measured by flow cytometry using conformation specific monoclonal antibodies Vn04-09 and Vn04-16, that preferentially recognize
prefusion and acid-activated forms of the H5N1 HA protein, respectively. (F) Activation pH of the HA protein, expressed as the midpoint of the pH of
conformational changes (closed bars) and the highest pH at which syncytia formation occurs (open bars). Error bars in panels B, C, and F represent
the standard deviation of triplicate experiments.
doi:10.1371/journal.ppat.1002398.g001
Figure 2. Enzymatic activities of the NA proteins from MP and
HP influenza viruses. NA enzymatic activity was determined by using
a fluorescence-based assay for transiently expressed NA protein (A) and
for prestandardized virus (B).
doi:10.1371/journal.ppat.1002398.g002
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and 6.0, respectively, and promoted the most pathogenicity in
chickens with the lowest LD50 values of 0.1 and 0.02 log10 EID50/
mL, respectively. All of the HAs that had activation pH values less
than 5.5 promoted reduced pathogenicity in chickens, resulting in
LD50 values greater than 0.5 log10 EID50/mL. For HP HA, the
presence of the more-active HP NA resulted in an activation pH of
5.7 and an LD50 value of 0.1 EID50/mL, whereas the presence of
the less-active MP NA decreased the activation pH to 5.4 and
lowered the pathogenicity to an LD50 value of 0.67 EID50/mL.
Conversely for MP HA, the presence of the less-active MP NA
resulted in an activation pH of 5.3 and an LD50 value of
3.7 EID50/mL, whereas the presence of the more-active HP NA
increased the activation pH to 5.45 and enhanced the pathoge-
nicity to an LD50 value of 1.7 EID50/mL. In some cases when
switching NA partners, the relationship between HA activation pH
and pathogenicity was less pronounced. For example, the HP HA
+ MP NA combination resulted in an HA activation pH of 5.4 and
an LD50 value of 0.67 EID50/mL while the MP HA + HP NA
combination had a slightly higher activation pH of 5.45 but was
less pathogenic with an LD50 value of 1.7 EID50/mL. While a loss
of balance between HA’s receptor-binding activity and NA’s
enzymatic activity [18] could potentially cause such a discrepancy
when the NA partner is switched, another unidentified mechanism
may play a role instead as the presence of either NA resulted in
similar receptor-binding avidities for MP and HP HA (Figure 1C).
Overall, though, the data reveal a trend in which an increase in
the pH of activation of the HA protein is associated with increased
pathogenicity in chickens within the observed pH range of 5.2 to
6.0.
Crystal structures of H5N1 HA proteins
To gain insights into the structural basis for altered HA acid
stability, we determined the crystal structures of the prefusion
forms of the MP and HP HA proteins (Table 1). One crystal form
of the MP HA protein was obtained at pH 8.5, and two crystal
forms of the HP HA protein were obtained at pH 6.6, all above
the low pH thresholds for conformational changes for the two
proteins. The overall folds of the MP and HP HA proteins (H5N1
clade 3) are very similar to each other (Figures 5D and S3) and to
those of the previously determined HA structures from isolates A/
Figure 3. Biochemical properties of wild-type and mutant HA proteins. (A) The pH of HA activation was determined as the average of the
highest pH at which syncytia formation occurs and the midpoint of the pH of conformational changes. (B) HA protein expression. Closed bars
represent total expression as determined by using Western blot analysis, and open bars represent cell-surface expression analyzed by flow cytometry.
(C) HA protein cleavage ratio, measured as described in Figure 1A. (D) Hemadsorption of chicken and turkey erythrocytes to cell surface-expressed
HA protein. Wild-type and mutant HP HAs were co-expressed in presence HP NA in all experiments. Values depict the average 6 standard deviation
of at least 3 independent experiments (for total expression and cleavage) or triplicate experiments for surface expression and hemadsorption. HP,
highly pathogenic. MP, moderately pathogenic. rHA1, HP HA possessing D104N, I115T, E131D, and L142H mutations.
doi:10.1371/journal.ppat.1002398.g003
Figure 4. HA activation pH and pathogenicity in chickens. The
activation pH values are averages of the midpoint pH of conformational
changes and the highest pH at which syncytia form. Pathogenicity is
expressed as the reciprocal of the LD50 values in chickens.
doi:10.1371/journal.ppat.1002398.g004
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[22,23]. Of the seven differing residues, 331 is in the polybasic
cleavage site and is not present in the cleaved structures, 104 and
115 are within the vestigial esterase sub-domain in the RBD, and
131, 142, 216, and 221 are within the receptor-binding sub-
domain in the RBD (Figure 5B,C).
An overlay of the RBD, which includes the receptor-binding
sub-domain and the vestigial esterase sub-domain, shows that the
six varying residues induce no substantial differences in the a-
carbon backbone structures of two prefusion HA strains
(Figure 5D). The RMSD values (on a-carbons) between the RBDs
of MP HA and HP HA crystal forms 1 and 2 are 0.31 A ˚ and 0.27
A ˚, respectively. The receptor-binding pocket residues had no
differences in conformation between the MP and HP HA
structures, and mutations at residues 131 and 142 distal to the
receptor-binding pocket did not alter the backbone structure
(Figure S4). The most significant differences occur between the
two crystal forms of the HP HA protein, specifically, in the B loops
of the HA2 stalk domain along with parts of the vestigial esterase
sub-domain (not including the 110-helix) and the F’ fusion sub-
domain (Figures 5C and S5A-C). Both crystal forms were grown in
identical solutions at pH 6.6, 0.9 pH units above its activation pH
of 5.7, but display different crystal-packing interactions in the B
loop region. The HA2 B loops from H5N1 isolates VN1194 and
VN1203 also adopt ‘‘in’’ and ‘‘out’’ forms, respectively (Figure
S5F), despite both proteins having identical residues in this region
and their crystals being grown at similar pH values of 6.5 and 6.55
[22,23]. VN1203, which adopts the ‘‘out’’ form in the absence of
antibody, adopts the ‘‘in’’ form when bound to antibody [24,25]
(Figure S5F). Because the various prefusion H5N1 HA proteins
adopt either ‘‘in’’ or ‘‘out’’ forms of the B loop in similar
conditions and with little apparent structural consequence, the
apparently flexible B loop may have little functional relevance in
the prefusion conformation of H5N1 HA.
Residues 216 and 221 in the receptor-binding sub-domain
interact with residues in adjacent monomers across the RBD
trimer interface (Figure 5B). In MP HA, E216 makes a hydrogen
bond with neighboring RBD backbone amide R212 (Figure 6B),
although this hydrogen bond is found only in two of the three
E216 residues in the HA trimer. The lack of hydrogen bonding by
the third E216 could be biologically relevant, helping to destabilize
HA, or could be due to a crystallographic artifact. In HP HA,
K216 makes a hydrogen bond with neighboring RBD backbone
carbonyl N210 (Figure 6B). We found that a K216E mutation
increased the pH of activation of HP HA by 0.4 pH units (Figure
S2). However, the presence of an E216 residue did not seem to
have a dominant effect in the context of MP HA, which contains
six other mutations and has an overall decreased pH of fusion
compared to HP HA (Figure 1). Compared to P221 in MP HA,
S221 in HP HA forms a hydrogen bond to the D241 side-chain in
an adjacent monomer across the RBD-RBD interface (Figure 6B).
While one might have expected that a S221P mutation would
destabilize HA by breaking a hydrogen bond and introducing a
proline, we found that an S221P mutation had the opposite effect
in the background of HP HA, decreasing the activation pH from
5.7 to 5.5 (Figure S2A). Perhaps the rigidity of a proline at residue
221 stabilizes this region. It has been previously hypothesized for
H5N1 and demonstrated for H3N2 (X31 strain) that HA stability
is regulated by salt bridges across the RBD-RBD interface and that
an alteration in HA stability may play a role in influenza virus
infectivity [26]. In the present study, the structural and
biochemical results on H5N1 mutations at residues 216 and 221
Table 1. Crystallographic data.
Data collection*
Crystal HP HACrystal form 1 HP HA Crystal form 2 MP HA
Space group P321 P321 P21
a, b, c (A ˚) 112.6, 112.6, 134.7 111.9, 111.9, 192.1 69.4, 241.1, 70.1
a, b, c (u) 90.0, 90.0, 120.0 90.0, 90.0, 120.0 90.0, 116.7, 90.0
Resolution (A ˚) 50.0–3.1 (3.21–3.10) 50.0–2.95 (3.06–2.95) 50.0–2.5 (2.59–2.50)
Rmerge 0.151 (0.459) 0.119 (0.480) 0.104 (0.431)
I/sI 17.7 (5.3) 22.8 (6.1) 17.7 (2.3)
Completeness (%) 100 (99.9) 99.9 (99.7) 96.0 (72.8)
Redundancy 11.0 (9.8) 12.6 (11.1) 4.8 (2.8)
Refinement
Resolution (A ˚) 50.0–3.1 50.0–2.95 50.0–2.5
No. reflections 17,391 28,027 64,349
Rwork/Rfree{ 0.217 / 0.264 0.238 / 0.251 0.221 / 0.265
Ramachandran (%)
Favored 92.1 92.4 95.1
Allowed 7.9 7.6 4.9
Outliers 0.0 0.0 0.0
RMS deviations
Bond lengths (A ˚) 0.008 0.009 0.007
Bond angles (u) 1.117 1.287 1.020
*Data were collected from a single crystal. Values of the highest-resolution shell are shown in parentheses.
{Rfree was calculated using 5% of the reflections.
doi:10.1371/journal.ppat.1002398.t001
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RBD-RBD interface also regulate H5N1 HA acid stability
(Figure 6B, S2).
The higher activation pH of HP HA compared to MP HA was
largely mapped to differences in residues 104 and 115 (Figure 3A),
which are located at the N- and C-termini of the 110-helix in the
vestigial esterase sub-domain of the RBD (Figure 5). In the
prefusion conformation, the 110-helix in HA1 interacts with the
interhelical B loops of two protomers in HA2 (Figure 6A). Most
notably, HA1 residues E107 and K109 in the 110-helix form salt
bridges with HA2 residues R76 and E69, respectively. This
interaction may stabilize the metastable structure by preventing
the B loops from springing out to their coiled-coil form or,
alternatively, by stabilizing the RBD head domains to prevent
their dissociation from the HA2 stalk after B loop structural
changes are initiated by low pH [27]. These salt bridges are clearly
important because E107 and K109 are more than 99.7%
conserved amongst sequenced H5N1 HA proteins, and R76 and
E69 are 100% conserved. The structures suggest that the sequence
variations at residues 104 and 115 modulate the stability of the
110-helix and, consequently, the interactions between the 110-
helix and the stalk domain. We hypothesize that the negatively
charged D104 in HP HA forms less favorable interactions with the
neighboring L73 at the top of the HA2 coil in the prefusion
conformation than does the polar N104 in MP HA (Figure 6A).
T115 in MP HA forms a hydrogen bond with the backbone
carbonyl oxygen of L111, thereby capping and stabilizing the C-
terminal end of the 110-helix. I115 in the HP HA does not form
this hydrogen bond, and the stabilizing capping interaction is
therefore absent. Overall, we suggest that the combination of
D104N and I115T mutations found in MP HA promotes the
stabilization of the 110-helix and thereby stabilizes the prefusion
form of the HA protein, lowering its pH of activation and,
consequently, attenuating the virus.
Discussion
The goal of the current study was to understand how amino
acid variations in the HA protein contribute to differences in
pathogenicity between two H5N1 influenza virus isolates. Our
analyses revealed that H5N1 pathogenicity in chickens correlates
with the activation pH of the HA protein. Specifically, an increase
in the pH of activation of the HA protein from 5.3 to 5.7 was
associated with the greater pathogenicity of the A/chicken/Hong
Kong/YU562/2001 isolate in chickens compared to the A/goose/
Hong Kong/437-10/1999 isolate. Other factors are largely similar
including their prefusion structures, expression levels, cleavage
levels, and receptor-binding properties. We have also shown that
naturally occurring mutations in the HA proteins of circulating
H5N1 influenza viruses have altered the acid stability of the HA
protein. Six of the 7 available HA protein sequences from H5N1
viruses sampled in 1999 (Table 2), including the MP 437-10
isolate, contain the N104 and T115 residues that we found to
Figure 5. Crystal structures of the MP and HP HA proteins. (A) Schematic of the HA protein after proteolytic cleavage into HA1 and HA2
subunits. The receptor-binding domain (RBD) consists of the receptor-binding sub-domain (green) and the vestigial esterase sub-domain (yellow).
The F’ fusion sub-domain in HA1 is colored blue and the HA2 stalk domain is colored red. The locations of the 7 amino acids that differ between the
MP and HP HA proteins are highlighted in magenta. (B) Crystal structure of MP HA trimer determined at 2.50A ˚. One protomer is colored as in panel A
(with HA1 in blue, HA2 in red, and 6 amino acids that differ in HP HA shown in magenta spheres). The seventh amino acid (337) that differs in HP HA
is removed after cleavage at the polybasic cleavage site between HA1 and HA2. Glycosylation carbohydrates observed in the electron-density maps
at HA1 residues Asn34 and Asn169 are shown as a ball-and-stick model. The remaining 2 HA protomers are colored grey. (C) Crystal structure of one
protomer of MP HA. The domains of the protein are identified with color: receptor-binding sub-domain (green), vestigial esterase sub-domain
(yellow), F’ fusion sub-domain (blue), and HA2 stalk domain (red). Important structural features include the 110-helix in the vestigial esterase sub-
domain and helix A, B loop, and helix C in the HA2 stalk domain. (D) Superposition of 1 protomer from the crystal structure of MP HA (blue) and 2
crystal structures of HP HA (yellow). HP HA crystallized in 2 forms; their structures were determined at 3.10A ˚ (Crystal form 1) and 2.95A ˚ (Crystal form
2). The coordinates for all 3 crystal structures have been deposited at the Protein Data Bank (PDB entry 3S11 [MP HA], PBD entry 3S12 [HP HA Crystal
form 1], and PDB entry 3S13 [HP HA Crystal form 2]). All residues are labeled using H3 numbering.
doi:10.1371/journal.ppat.1002398.g005
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pathogenicity. In contrast, none of the available 2847 HA protein
sequences obtained since 2000 contain the N104/T115 combina-
tion, whereas approximately 93% contain the D104/I115
combination found in the HP YU562 isolate that leads to an
increased HA activation pH and increased pathogenicity. These
epidemiological observations suggest that there has been a
negative selection pressure against the N104/T115 combination
Figure 6. Structures at sites of sequence variation between the MP and HP HA proteins. (A) Zoomed-in stereo view of residues 104 and
115 at the N- and C-terminal ends of the 110-helix of HA1 in MP HA (blue) and HP HA (yellow). The corresponding HA2 backbone is colored red and
HA2 sidechains of the other two protomers are colored white. Residues from HA2 are denoted with a ‘‘2’’ subscript. Dotted lines represent hydrogen
bonds and are colored to match the corresponding HA protein with MP HA in blue and HP HA in yellow. Note the interaction between the 110-helix
with the B loops from 2 HA2 protomers. (B) Zoomed-in stereo view of residues 216 and 221 in MP HA (blue) and HP HA (yellow) and their location at
the trimer interface. The adjacent protomers across the RBD-RBD interface for MP and HP HA are all shown in gray. In both A and B, the left and
middle panels represent the divergent pair of stereoimages while the middle and right panels represent the convergent pair of stereoimages. All
residues are labeled using H3 numbering.
doi:10.1371/journal.ppat.1002398.g006
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PLoS Pathogens | www.plospathogens.org 7 December 2011 | Volume 7 | Issue 12 | e1002398of residues that are found in the MP virus that has prevented its
propagation in avian species, and this may be related to the
relatively low pH that is required to trigger membrane fusion.
Here, we found that sequence variations in the RBD (which
includes the receptor-binding and vestigial esterase sub-domains)
do not alter the structure of the prefusion RBD but instead
modulate the activation pH of the H5N1 HA protein. While such
a phenotype may be unexpected, a D112G mutation in the HA2
stalk domain of A/Aichi/68 (H3N2) has also been shown to alter
HA acid stability yet involves only the replacement of the Asp
sidechain with a water molecule at the mutation site, causing no
detectable changes in the backbone or surrounding protein
structure in prefusion HA [28]. Further evidence that the RBD
forms a stable structure in the prefusion conformation is suggested
by the fact that the isolated RBD from A/H1N1/2009, E. coli-
expressed and refolded [29], has recently been shown to adopt the
same fold [30] as the RBD in the intact, prefusion HA ectodomain
[31,32]. The structures of a mutant H2N2 HA protein (A/Japan/
305/57) determined from crystals grown at pH 8.1 and 5.3 suggest
that early structural changes in HA after acid activation include
bulging out of the HA2 B loop and distortions in the HA1 vestigial
esterase and F’ fusion sub-domains (Figure S5G-I) [27]. These
reversible structural changes were suggested to correspond to an
early intermediate of the HA protein after acid activation and may
help initiate global HA refolding. We also observed the two forms
of the B loop, vestigial esterase sub-domain, and F’ fusion sub-
domain in the two different crystal forms of the HP A/chicken/
Hong Kong/YU562/2001 (H5N1) HA protein (Figure S5A-C),
although both H5N1 HA crystals were grown in identical solutions
at pH 6.6 (0.9 pH units above its pH of activation). While the two
HP H5N1 HA structures suggest that the observed differences in
the B loops, vestigial esterase sub-domain, and F’ fusion sub-
domain in the prefusion structures reported here are due to
differing crystallographic environments, it is possible that upon
low-pH activation the H5N1 HA protein favors the ‘‘out’’ form of
the B loop and pivoting of the F’ fusion sub-domain similar to that
which is observed when the H2 HA protein is exposed to acidic
pH [27].
Mutations to amino-acid residues other than 104 and 115 can
modulate HA protein activation and influenza virus pathogenicity.
For example, in a proof-of-concept study, we recently showed that
mutations to conserved residues in the stalk domain (albeit,
mutations that have not been observed in circulating H5N1
viruses) alter HA acid stability and, as a result, modulate H5N1
replication, pathogenicity, and transmissibility in ducks [16]. In
that study, recombinant A/chicken/Vietnam/C58/2004 (H5N1,
clade 1) viruses containing HA proteins activated at pH values of
5.6 and 5.9 were highly virulent and transmissible in mallards,
while those activated at pH values of 5.4 and 6.3 were avirulent
and not transmissible. Taken together, our previous [16] and
present data suggest that high levels of H5N1 influenza virus
infection and pathogenicity in avian species may be supported by a
relatively narrow range of HA protein activation pH values,
minimally pH 5.6 to 6.0.
In general, opposing pressures may limit the activation pH of
the HA protein to an optimal range that may shift depending on
viral and host factors. A relatively low pH of HA protein activation
would be needed to avoid inactivation in the environment or in
mildly acidic tissues, whereas the activation pH would still need to
be high enough to allow membrane fusion to occur before the
virus is trafficked to the lysosome. Circumstantial and direct
evidence support this notion. First, the acid stabilities of influenza
virus HA proteins range from pH 4.6 to 6.0 and vary by subtype
and host species [33]. Second, the adaptation of H3N2 viruses
from eggs to mammalian cells [15] and of H7N3 viruses from
ducks to turkeys [14] resulted in HA mutations that altered the
acid stability of the HA protein. Third, in the presence of high
concentrations of amantadine, a compound that raises endosomal
pH, resistant variants of H3N2, H7N1, and H7N7 viruses have
been selected that have increased HA activation pH values [34–
37].
In the present work, a higher level of NA enzymatic activity
contributed to an increase in the activation pH of the HA protein
and was associated with greater virulence by HP YU562 virus
compared to MP 437–10 virus. Compared to expression of HA
alone, coexpression of NA together with HA has previously been
shown to increase the pH of activation of the H5N1 HA protein by
0.5 pH units in the absence but not the presence of the NA
inhibitor oseltamivir [16], further demonstrating a link between
NA activity and destabilization of the HA protein. The mechanism
by which NA enzymatic activity augments HA protein fusogenic
activity is unknown; however, cleavage of sialic-acid containing N-
linked glycosylation sites on the HA protein may decrease the
energy required to trigger HA conformational changes by
destabilizing the prefusion form of individual HA trimers.
Alternatively, enhanced cleavage of HA glycosylation sites could
potentially promote the synchronized activation and refolding of
adjacent, interacting HA trimers [38]. Increased NA enzymatic
activity could also reduce interference that would occur if HA
trimers bound to other HA trimers, NA proteins, glycoproteins, or
glycolipids. However, a very large reduction in NA enzymatic
activity might be needed to cause such interference in the first
place. The importance of glycosylation sites in regulating HA
activation and influenza virus replication has been demonstrated
previously for A/FPV/Rostock/34 (H7N1), whose HA protein is
destabilized by the removal of glycosylation sites in the stalk
domain [39]. Complementation of HA protein fusogenic activity
by NA enzymatic activity may depend on influenza virus subtype.
For example, NA co-expression resulted in increased membrane
fusion by the HA proteins from HPAI H7N4 and human H1N1
influenza viruses [20], while the addition of exogenous neuramin-
idase had no effect on membrane fusion mediated by human
H2N2 and H3N2 HA proteins but instead led to an increase in
receptor-binding activity by HA [40,41].
Influenza virus pathogenicity is a polygenic trait that is
modulated by a combination of viral and host factors [1,6,7].
Although an optimal activation pH of the HA protein appears to
be necessary for high pathogenicity by H5N1 influenza viruses in
Table 2. Prevalance of amino-acid residues at positions 104
and 115 of the HA protein.
Amino acid residue Prevalance






D F, L, or V 1.39
A, E, G, S, V, or Y I 0.47
*HA gene sequences of H5N1 viruses collected between 1996 and May 2011 are
included. Boldface and underlined type indicate the amino acid combinations
at positions 104 and 115 in the MP and HP HA proteins, respectively.
doi:10.1371/journal.ppat.1002398.t002
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pathogenicity in the absence of a polybasic cleavage site, host-
appropriate receptor-binding specificity, or an efficient polymer-
ase. Moreover, if the optimal activation pH differs between avian
and mammalian species, additional studies will be needed to
determine whether alterations in HA acid stability may contribute
to the pandemic potential of H5N1 influenza viruses.
Materials and Methods
Cloning
HA genes from A/goose/Hong Kong/437-10/1999 (MP) and
A/chicken/Hong Kong/YU562/2001 (HP) H5N1 influenza
viruses were cloned into pHW2000, pCAGGS, and pAcGP67B
plasmids as described previously [16,19,22]. Point mutations were
introduced by QuickChange mutagenesis (Stratagene).
Transient expression of HA and NA
Monolayers of Vero or BHK-21 cells at 70% to 80% confluency
in 6-well plates were transiently transfected with pCAGGS HA
(1.0 mg) and pCAGGS NA (0.1 mg) plasmids by using a
Lipofectamine Plus expression system (Invitrogen) [19]. After 4
hours at 37uC, the transfection medium was replaced with DMEM
containing 10% fetal bovine serum (and 1% glutamine for BHK-
21 cells), and cells were incubated for 16 h at 37uC.
Expression and activation pH of HA protein
Biochemical analyses were performed as described previously
[19]. Briefly, HA proteins were resolved on 4-12% NuPAGE
BisTris polyacrylamide-SDS gels (Invitrogen) and visualized on a
Typhoon 9200 imager (GE Healthcare, Waukesha, WI). HA
surface expression was determined by using flow cytometry with
the primary monoclonal HA antibody Vn04-02 (1:2000) and
fluorescein-conjugated, AffiniPure donkey anti-mouse IgG (H+L,
Jackson Immuno Research, West Grove, PA) secondary antibody.
The pH of HA conformational changes (to 0.1 pH resolution) was
determined by using flow cytometry and monoclonal antibodies
Vn04-09 and Vn04-16, which preferentially bind to the prefusion
and postfusion HA forms, respectively [21]. To determine the pH
of membrane fusion, BHK-21 cell monolayers were transfected
with pCAGGS HA and pCAGGS NA plasmids as described
above or infected with viruses at an MOI of 3 PFU/cell. At 16 h
posttransfection or 6 h postinfection, cells were washed and
overlaid with PBS+ (PBS containing calcium and magnesium at
0.1 g/liter) with the pH adjusted to 0.1 resolution with 0.1 M
citric acid. The pH of fusion was expressed as the highest pH at
which syncytium formation was observed.
Hemadsorption
Sixteen hours after transfection, monolayers of Vero cells were
washed twice with PBS+, overlaid with 1% chicken or turkey
erythrocytes, and incubated at 37uC for 30 min. Monolayers were
then washed 3 times with DMEM (phenol red-free) to remove
unbound red blood cells and lysed with 1X RBC lysis buffer
(eBioscience). The amount of bound erythrocytes was determined
by measuring the absorbance of clarified lysate at 415 nm by using
a Synergy-2 Multi-mode microplate reader (BioTek, Winooski,
VT).
NA enzymatic activity
NA enzymatic activity was determined by using a fluorescence-
based NA assay with methyl umbelliferone N-acetyl neuraminic
acid (MUNANA; Sigma, St Louis, MO) as a substrate (final
concentration of 100 mM) [42]. Fluorescence due to release of 4-
methylumbelliferone was measured by using a Synergy-2 Multi-
mode microplate reader. The enzyme activity of transiently
expressed NA was determined as the quantity (pmol) of 4-
methylumbelliferone sodium salt (Sigma) generated during a
30 min incubation at 37uC and was standardized to 0.1 mg total
protein by using a bicinchoninic acid assay (Sigma). The NA
enzyme activity of varying titers of HP and MP viruses was
standardized to the relative PFU/mL titers.
HA ectodomain production
Purified ectodomains of the HP and MP HA proteins were
prepared as described previously [22] using a baculovirus
expression system (BD Biosciences) and Sf9 insect cells. Secreted
HA ectodomains were purified by metal affinity chromatography
followed by thrombin digestion of the purification tag. Trypsin was
used to cleave HA into the active HA1/HA2 form. HA proteins
were further purified by size-exclusion chromatography and
concentrated to 1.4 mg/mL (MP HA) or 3.0 mg/mL (HP HA).
Crystal structure determination
HA protein crystals were grown by the hanging-drop vapor
diffusion method at 18uC. MP HA crystallized in a well solution of
23% PEG 3350 and 0.1 M Tris-HCl, pH 8.5. From HP HA, two
crystal forms were obtained in the same crystallization conditions
(1.62 M ammonium sulphate, 0.1 M sodium cacodylate, pH 6.6).
Crystals were transferred to a well solution containing 25%
glycerol (MP HA) or 25% ethylene glycol (HP HA) for 1–2
minutes before freezing in liquid nitrogen. Diffraction data were
collected at cryogenic temperature at X-ray wavelength 1.00 A ˚
from the Southeastern Regional Collaborative Access Team’s 22-
ID and 22-BM beamlines at the Advanced Photon Source
(Argonne National Laboratory, Chicago, IL). Data processing
and reduction was completed by using HKL-2000 software [43].
HA ectodomain structures were determined by molecular
replacement using the program Phaser [44]. From HP HA crystal
form 1, a solution was obtained by using a single HA protomer
from the crystal structure of the HA from H5N1 A/Vietnam/
1203/2004 (PDB entry 2FK0). For MP HA, the HP HA crystal
form 1 structure was used as a molecular replacement model. For
HP HA crystal form 2, the best molecular replacement solution
was obtained by using a single HA protomer from MP HA’s
crystal structure. Model building was performed by using Coot
[32] followed by iterative rounds of simulated annealing using
Phenix [45] and restrained refinement using the CCP4 software
suite’s REFMAC5 [46]. Refinement was monitored by following
the Rfree value calculated for a random subset (5%) of reflections
omitted from refinement. The final models were validated by using
MolProbity [47] and are numbered according to H3 numbering
based on the crystal structure of A/Vietnam/1203/2004 H5 HA
(PDB entry 2FK0). We used the H3 numbering scheme in this
manuscript, which differs from the H5 numbering that was used
previously [17].
After simulated annealing of HP HA crystal form 2, the electron
density for the region of the stalk domain that is closest to the viral
membrane was very poor due to irregular crystal packing within
this region. The structural model of HP HA crystal form 2 was
guided by B-factors: residues with B-factors higher than 90 were
not included in the model. The final model of HP HA crystal form
2 contains HA1 residues 43–312 and HA2 residues 59–101 (H3
numbering).
HA protein sequence analysis
HA protein sequences published between 1996 and 2011 (as of
May 2011) were obtained from NCBI’s Influenza Virus Resource
HA Acid Stability and H5N1 Influenza Pathogenicity
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ratory sequences or sequences that did not cover the amino-acid
positions of interest in this study were excluded. Sequences were
aligned by using the ClustalW tool included in BioEdit v7.0.9 [48].
The frequencies of amino-acid residues were calculated for HA1
positions 104, 107, 109, and 115 and HA2 positions 73, 69, and 76
(in H3 numbering).
Supporting Information
Figure S1 Expression of HA proteins cotransfected with NA
proteins in Vero cells. (A) Surface expression of wild-type HP and
MPHA proteins cotransfected with wild-type NAproteins asmeasured
by flow cytometry. (B and C) Surface expression of wild-type (wt) and
mutant HP HA proteins cotransfected with the HP NA protein as
measured by flow cytometry. (D–F) Confocal microscopic images
showing expression of HA proteins on unpermeabilized Vero cells. (D)
Confocal images of HP HA cotransfected with HP NA. (E) Confocal
images of MP HA cotransfected with MP NA. (F) Confocal images of
untransfected (mock) cells. At 16 h posttransfection, Vero cells were
stained with conformation-independent Vn04-02 mouse monoclonal
primary antibody. FITC-conjugated antibody and Alexa Fluor 555-
conjugated antibody were used as secondary antibodies for flow
cytometry and confocal microscopy, respectively. Untransfected cells
were used as a control (mock). For confocal microscopy, nuclear
staining was performed using DAPI, 10 mms c a l eb a r sa r es h o w n ,a n d
a Zeiss LSM 510 META laser scanning confocal microscope was used.
(TIF)
Figure S2 Biochemical characterization of mutant HP HA
proteins. (A) The pH of HA protein activation determined as the
average of the pH values of conformational change and those of
syncytia formation. (B) HA protein expression. Closed bars
represent total expression as determined by using Western blot
analysis, and open bars represent cell-surface expression analyzed
by flow cytometry. (C) HA protein cleavage ratio. (D) Hemad-
sorption of chicken and turkey erythrocytes to cell surface-
expressed HA normalized to 100% HP HA hemadsorption. Wild-
type and mutant HP HA proteins were co-expressed in the
presence of the HP NA protein in all experiments. Values shown
are average 6 standard deviation of at least 3 independent
experiments (for total expression and cleavage) or triplicate
experiments (for surface expression and hemadsorption). Asterisks
indicate a significant difference (P,0.01) as determined by
unpaired two-tailed t-test. HP, highly pathogenic.
(TIF)
Figure S3 Crystal structures of MP HA and HP HA proteins.
(A) Crystal structure of MP HA trimer determined at 2.50A ˚. One
protomer is colored with HA1 in blue and HA2 in red.
Glycosylation carbohydrates observed in the electron-density
maps at HA1 residues Asn34 and Asn169 are shown as a ball-
and-stick model. The remaining 2 HA protomers are colored grey.
(B) Crystal form 1 structure of HP HA trimer determined at
3.10A ˚. (C) Crystal form 2 structure of HP HA trimer determined
at 2.95A ˚. Part of the structure is missing because it is packed in a
random fashion throughout the crystal.
(TIF)
Figure S4 Zoomed-in stereo view of residues 131 and 142 and
their location with respect to the receptor-binding site in MP HA
(blue) and HP HA (yellow). Dotted lines represent hydrogen bonds
and are colored to match the corresponding HA protein. The left
and middle panels represent the divergent pair of stereoimages
while the middle and right panels represent the convergent pair of
stereoimages. All residues are labeled using H3 numbering.
(TIF)
Figure S5 Comparison of HAstructures.(A)Superpositionofone
protomer from the 2 crystal structures of HP HA. (B) Superposition
of the HA1 chains from the 2 crystal structures of HP HA. (C)
Superposition of the HA2 chains from the 2 crystal structures of HP
HA. The variation between the interhelical B loops (‘‘in’’ or ‘‘out’’
conformations) in the HP HA structures from two crystal forms at
the same pH is likely the result of crystal packing differences. (D)
Superposition of 1 protomer from four H5N1 HA crystal structures:
VN1194 (PDB entry, 2IBX), VN1203 (PDB entry, 2FK0), VN1203
bound to antibody F10 (PDB entry 3FKU), and VN1203 bound to
antibody CR6261 (PDB entry 3GBM). For clarification, the bound
antibodies are not shown in the figure. (E)Superposition of the HA1
chains from the four H5N1crystalstructures in D. (F) Superposition
of the HA2 chains from the four H5N1 crystal structures in D. (G)
Superposition of one protomer from two H2 HA crystal structures.
H2 HA (P63) corresponds to PDB entry 3QQB and H2 HA (P21)
corresponds to PDB entry 3QQO. (H) Superposition of the HA1
chains from thetwocrystalstructuresof H2HA.(I)Superposition of
the HA2 chains from the two crystal structures of H2 HA. The
crystallization space groups are described in parentheses; the
crystallization pH is also indicated.
(TIF)
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